AMOROSO, VITO
 Distribuzione geografica
Continente #
NA - Nord America 3.578
AS - Asia 1.790
EU - Europa 1.702
SA - Sud America 325
Continente sconosciuto - Info sul continente non disponibili 89
AF - Africa 33
OC - Oceania 10
Totale 7.527
Nazione #
US - Stati Uniti d'America 3.487
SG - Singapore 697
CN - Cina 491
DE - Germania 423
IT - Italia 379
BR - Brasile 269
UA - Ucraina 168
HK - Hong Kong 158
FI - Finlandia 145
VN - Vietnam 142
RU - Federazione Russa 134
GB - Regno Unito 108
PL - Polonia 89
FR - Francia 75
BD - Bangladesh 72
TR - Turchia 62
IN - India 57
CA - Canada 54
IE - Irlanda 40
CZ - Repubblica Ceca 31
SE - Svezia 25
ID - Indonesia 22
AR - Argentina 21
NL - Olanda 20
MX - Messico 18
BE - Belgio 15
ES - Italia 14
ZA - Sudafrica 14
IQ - Iraq 13
JP - Giappone 11
EC - Ecuador 10
UZ - Uzbekistan 10
AU - Australia 9
PK - Pakistan 9
CH - Svizzera 7
CO - Colombia 7
PY - Paraguay 7
AT - Austria 6
AE - Emirati Arabi Uniti 5
JM - Giamaica 5
LT - Lituania 5
SA - Arabia Saudita 5
CL - Cile 4
EE - Estonia 4
ET - Etiopia 4
JO - Giordania 4
PH - Filippine 4
AM - Armenia 3
CR - Costa Rica 3
EG - Egitto 3
EU - Europa 3
HN - Honduras 3
IL - Israele 3
KZ - Kazakistan 3
LV - Lettonia 3
MA - Marocco 3
NG - Nigeria 3
PA - Panama 3
RO - Romania 3
TW - Taiwan 3
VE - Venezuela 3
AZ - Azerbaigian 2
DZ - Algeria 2
GR - Grecia 2
IR - Iran 2
LB - Libano 2
NP - Nepal 2
PE - Perù 2
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
FK - Isole Falkland (Malvinas) 1
GT - Guatemala 1
HU - Ungheria 1
IM - Isola di Man 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
KR - Corea 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
MM - Myanmar 1
MU - Mauritius 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 7.441
Città #
Fairfield 357
Ashburn 348
Singapore 347
Woodbridge 240
San Jose 189
Houston 163
Hong Kong 157
Seattle 136
Cambridge 135
Jacksonville 134
Chandler 123
The Dalles 114
Wilmington 114
Beijing 113
Ann Arbor 110
New York 103
Helsinki 93
Dallas 86
Warsaw 81
Los Angeles 69
Munich 68
Princeton 66
Council Bluffs 57
Istanbul 47
Ho Chi Minh City 45
Lauterbourg 45
Dublin 40
Boardman 38
Dearborn 37
Milan 37
Brescia 35
Turku 32
Redondo Beach 31
Columbus 30
Shanghai 30
Chicago 29
Santa Clara 29
Nanjing 28
Orem 27
Rome 27
Moscow 25
Brno 22
Hanoi 22
Changsha 20
London 20
Nuremberg 20
Nürnberg 20
Stockholm 20
São Paulo 20
San Francisco 19
Des Moines 16
Montreal 16
Nanchang 16
Toronto 15
Brooklyn 14
Jakarta 14
Mumbai 14
Buffalo 13
San Diego 13
Atlanta 12
Brussels 12
Poplar 12
Chennai 11
Hebei 11
Mexico City 11
Rio de Janeiro 11
Shenyang 11
Tokyo 11
Bergamo 10
Dalmine 10
Denver 10
Jinan 10
Romola 10
Belo Horizonte 9
Lappeenranta 9
Tashkent 9
Tianjin 9
Guangzhou 8
Haiphong 8
Jiaxing 8
Johannesburg 8
Olomouc 8
Amsterdam 7
Boston 7
Campinas 7
Hangzhou 7
Naples 7
Phoenix 7
Salt Lake City 7
San Mateo 7
Washington 7
Baghdad 6
Buenos Aires 6
Charlotte 6
Frankfurt am Main 6
Gliwice 6
Ningbo 6
Paris 6
Verona 6
Biên Hòa 5
Totale 4.673
Nome #
Excess of second tumors in denosumab-treated patients: A metabolic hypothesis 252
Neoadjuvant treatment approach: The rosetta stone for breast cancer? 215
Genetic Polymorphisms as Possible Factors Involved in the Onset of Anthracycline-Induced Cardiomyopathy 213
Comparative efficacy of palbociclib, ribociclib and abemaciclib for ER+ metastatic breast cancer: an adjusted indirect analysis of randomized controlled trials 212
Association of Fat Body Mass With Vertebral Fractures in Postmenopausal Women With Early Breast Cancer Undergoing Adjuvant Aromatase Inhibitor Therapy 205
Should Adjuvant Weekly Paclitaxel Be Considered Less Efficacious Than Anthracyclines Plus Cyclophosphamide for Lower Risk Patients With Early-Stage Breast Cancer? 198
Sacituzumab govitecan and radiotherapy in metastatic, triple-negative, and BRCA-mutant breast cancer patient with active brain metastases: A case report 194
Morphometric vertebral fractures in breast cancer patients treated with adjuvant aromatase inhibitor therapy: A cross-sectional study 193
Outcome of patients with lung adenocarcinoma with transformation to small-cell lung cancer following tyrosine kinase inhibitors treatment: A systematic review and pooled analysis 190
Regression of advanced neuroendocrine tumors among patients receiving placebo 189
Pathologic Complete Response As a Potential Surrogate for the Clinical Outcome in Patients With Breast Cancer After Neoadjuvant Therapy: A Meta-Regression of 29 Randomized Prospective Studies. 180
Adjuvant bisphosphonates in patients with breast cancer: Does the potency matter? 178
Investigational drugs targeting somatostatin receptors for treatment of acromegaly and neuroendocrine tumors. 175
Osimertinib in EGFR Mutation–Positive Advanced NSCLC 175
Serum vitamin D and prostate cancer prognosis: The story continues 169
When should everolimus be administered in the natural history of pancreatic neuroendocrine tumors? 169
Exemestane with ovarian suppression in premenopausal breast cancer. 169
Testosterone Levels and Prostate Cancer Prognosis: Systematic Review and Meta-analysis 168
Eribulin Treatment in Patients with Liver Metastatic Breast Cancer: Eight Italian Case Reports 168
Regorafenib-related erythrocytosis in metastatic extra-gastrointestinal stromal tumor: a case report 159
The Spread of SARS-CoV-2 Infection Among the Medical Oncology Staff of ASST Spedali Civili of Brescia: Efficacy of Preventive Measures 155
Eribulin in Heavily Pretreated Metastatic Breast Cancer Patients in the Real World: A Retrospective Study 153
The involvement of early stage breast cancer patients during oncology consultations in Italy: a multi-centred, randomized controlled trial of a Question Prompt Sheet versus Question Listing 153
Changes in eating habits and food preferences in breast cancer patients undergoing adjuvant chemotherapy 150
IFN-α in advanced well-differentiated neuroendocrine tumors: The neglected drug? 149
Efficacy of the DigniCap System in preventing chemotherapy-induced alopecia in breast cancer patients is not related to patient characteristics or side effects of the device 141
Gastrointestinal Toxicity of Antibody Drug Conjugates (ADCs) in Metastatic Breast Cancer: A Pooled Analysis 140
Outcome of patients with intrathyroidal thymic carcinoma: a pooled analysis 132
Ovarian Strumal Carcinoid: Case Report, Systematic Literature Review and Pooled Analysis 130
Management of neuroendocrine tumors: State of the art 129
Systemic therapies in patients with advanced well-differentiated pancreatic neuroendocrine tumors (PanNETs): When cytoreduction is the aim. A critical review with meta-analysis 129
Assessment of DXA derived bone quality indexes and bone geometry parameters in early breast cancer patients: A single center cross-sectional study 123
Changes in body composition in early breast cancer patients treated with aromatase inhibitors 121
Outcome of Patients With Metastatic Lung Neuroendocrine Tumors Submitted to First Line Monotherapy With Somatostatin Analogs 119
The Interaction of Lean Body Mass With Fat Body Mass Is Associated With Vertebral Fracture Prevalence in Women With Early Breast Cancer Undergoing Aromatase Inhibitor Therapy 118
Efficacy of Eribulin mesylate in older patients with breast cancer: A pooled analysis of clinical trial and real-world data 117
Efficacy of topic steroids in the management of asthma and chronic obstructive pulmonary disease in advanced non-small cell lung cancer patients during treatment with nivolumab 115
Taste Alterations Do Not Affect Change in Food Habits and Body Weight in Breast Cancer Patients 111
Is weight gain preventable in women with early breast cancer undergoing chemotherapy? A real-world study on dietary pattern, physical activity, and body weight before and after chemotherapy 109
Should everolimus be stopped after radiological progression in metastatic insulinoma? A “cons” point of view 104
Body composition in early breast cancer patients treated with adjuvant aromatase inhibitors: Does dietary counseling matter? 102
Immune-related adverse events as potential surrogates of immune checkpoint inhibitors’ efficacy: a systematic review and meta-analysis of randomized studies 95
Sleep disturbances and restless legs syndrome in postmenopausal women with early breast cancer given adjuvant aromatase inhibitor therapy 94
Taste alterations during neo/adjuvant chemotherapy and subsequent follow-up in breast cancer patients: a prospective single-center clinical study 91
Adjuvant denosumab for early breast cancer-Evidence and controversy 90
Endocrine and Neuroendocrine Tumors: A Special Issue 88
Efficacy and Safety of Lanreotide Autogel and Temozolomide Combination Therapy in Progressive Thoracic Neuroendocrine Tumors (carcinoid): Results from the Phase 2 ATLANT Study 85
Correction to: Changes in surgicaL behaviOrs dUring the CoviD-19 pandemic. The SICE CLOUD19 Study (Updates in Surgery, (2021), 73, 2, (731-744), 10.1007/s13304-021-01010-w) 82
Osteoblastic flare in a patient with advanced gastric cancer after treatment with pemetrexed and oxaliplatin: implications for response assessment with RECIST criteria 82
Long-lasting successful cerebral response with sorafenib in advanced renal cell carcinoma 78
Changes in surgicaL behaviOrs dUring the CoviD-19 pandemic. The SICE CLOUD19 Study 71
Regression of advanced neuroendocrine tumors among patients receiving placebo 61
Clinical practice guidelines for the management of non-functioning advanced GEP-NENs: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology (AIOM) in collaboration with the Italian Association for Neuroendocrine Tumors (ITANET) 51
Selpercatinib plus cemiplimab in RET positive medullary thyroid cancer patient with skin cancers 44
Predictors of survival outcomes in patients with neuroendocrine neoplasms: a real-world retrospective study 44
Totale 7.527
Categoria #
all - tutte 35.055
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.055


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022263 0 24 17 10 4 20 3 29 13 35 18 90
2022/2023364 39 10 9 22 35 87 3 31 59 13 36 20
2023/2024491 32 13 50 22 26 78 17 21 92 11 12 117
2024/20251.213 15 13 14 213 114 83 98 45 194 75 206 143
2025/20262.627 219 301 228 360 270 223 356 100 161 220 106 83
2026/2027155 85 70 0 0 0 0 0 0 0 0 0 0
Totale 7.527